T Pullar

Time to stop counting the tablets?

T Pullar, S Kumar, H Tindall et al. · Clinical Pharmacology & Therapeutics · 1989 · 233 citations

Drug Safety, Non-pharmacological Intervention, Preventive Medicine +13

BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists

Kuntal Chakravarty, Helen McDonald, T Pullar et al. · Lara D. Veeken · 2006 · 178 citations · Full text

Clinical Guidelines, Dermatology, Psoriatic Arthritis +17

Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily

T Pullar, A. J. Birtwell, Philip Wiles et al. · Clinical Pharmacology & Therapeutics · 1988 · 169 citations

Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.

T Pullar, John Hunter, H A Capell · BMJ · 1983 · 167 citations · Full text

Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.

R S Amos, T Pullar, D E Bax et al. · BMJ · 1986 · 145 citations · Full text

Pharmacotherapy, Psoriatic Arthritis, Inflammatory Arthritis +16